|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2006-12-5
|
|
pubmed:abstractText |
To undertake the first substantial clinical study of breast radiotherapy toxicity in BRCA1 and BRCA2 mutation carriers in the United Kingdom.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AhernRogerR,
pubmed-author:Ardern-JonesAudreyA,
pubmed-author:AshcroftLindaL,
pubmed-author:AshleySueS,
pubmed-author:BaildamAndrewA,
pubmed-author:BancroftElizabethE,
pubmed-author:BarrLesterL,
pubmed-author:Breast Unit of the Royal Marsden NHS Foundation Trust,
pubmed-author:EastonDouglasD,
pubmed-author:EcclesDianaD,
pubmed-author:EelesRosalindR,
pubmed-author:EvansGarethG,
pubmed-author:FernandoIndrajitI,
pubmed-author:GuiGeraldG,
pubmed-author:HodgsonShirleyS,
pubmed-author:HowellAnthonyA,
pubmed-author:McReynoldsKateK,
pubmed-author:PierceLoriL,
pubmed-author:RoyleGavinG,
pubmed-author:ShanleySusanS,
pubmed-author:ShortSusanS,
pubmed-author:TuttAndrewA,
pubmed-author:YarnoldJohnJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7025-32
|
|
pubmed:meshHeading |
pubmed-meshheading:17145824-Adult,
pubmed-meshheading:17145824-Aged,
pubmed-meshheading:17145824-Breast Neoplasms,
pubmed-meshheading:17145824-Case-Control Studies,
pubmed-meshheading:17145824-Female,
pubmed-meshheading:17145824-Follow-Up Studies,
pubmed-meshheading:17145824-Genes, BRCA1,
pubmed-meshheading:17145824-Genes, BRCA2,
pubmed-meshheading:17145824-Germ-Line Mutation,
pubmed-meshheading:17145824-Great Britain,
pubmed-meshheading:17145824-Heterozygote,
pubmed-meshheading:17145824-Humans,
pubmed-meshheading:17145824-Middle Aged,
pubmed-meshheading:17145824-Neoplasm Staging,
pubmed-meshheading:17145824-Radiotherapy,
pubmed-meshheading:17145824-Retrospective Studies,
pubmed-meshheading:17145824-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom.
|
|
pubmed:affiliation |
Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. Susan.Shanley@rmh.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
